Given that constitutive NF-κB and STAT3 activation obstructs with apoptotic effect of chemotherapy, activation of these pathways may be responsible for the poor outcomes observed after CHOP treatment in EBV+ DLBCL. This evidence concerns the gene STAT3 and diffuse large B-cell lymphoma.